Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
A performance improvement project to increase appropriate reporting of weekly paclitaxel infusion related hypersensitivity adverse drug reactions at a major tertiary cancer center.
- In: Hospital Pharmacy - Posters
- At: Basel (Switzerland) (2008)
- Type: Poster
- Poster code: HPS-P-005
- By: LAL, Lincy (University of Texas - MD Anderson Cancer Center, Houston, United States of America)
- Co-author(s): Dana, William (University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America)
Gerber, Donna (University of Texas - MD Anderson Cancer Center, HOUSTON, United States of America) - Abstract:
Objectives: This prospective performance improvement project identifies, intervenes, and measures the impact of a clinical safety and effectiveness program to increase and improve the rate of appropriate reporting of weekly paclitaxel infusion related hypersensitivity reactions in an electronic medical record (EMR) system at a major tertiary..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023